5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.47▼ | 1.47▼ | 1.47▼ | 1.46▼ | 1.46▼ |
MA10 | 1.49▼ | 1.49▼ | 1.49▼ | 1.46▼ | 1.47▼ |
MA20 | 1.49▼ | 1.49▼ | 1.49▼ | 1.47▼ | 1.48▼ |
MA50 | 1.55▼ | 1.52▼ | 1.52▼ | 1.49▼ | 1.50▼ |
MA100 | 1.51▼ | 1.49▼ | 1.49▼ | 1.49▼ | 1.66▼ |
MA200 | 1.51▼ | 1.52▼ | 1.54▼ | 1.49▼ | 1.83▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.003▼ | -0.004▼ | -0.004▼ | -0.002▼ | -0.002▼ |
RSI | 44.110▼ | 44.618▼ | 44.672▼ | 45.703▼ | 44.841▼ |
STOCH | 26.190 | 26.190 | 26.190 | 31.473 | 12.022▼ |
WILL %R | -92.857▼ | -92.857▼ | -92.857▼ | -83.333▼ | -93.517▼ |
CCI | -70.181 | -70.181 | -70.181 | -68.316 | -87.777 |
Wednesday, April 24, 2024 05:15 AM
CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK. Phase 1 part of combined Phase 1/2 study initiated as part of ...
|
Wednesday, April 24, 2024 03:15 AM
KELOWNA, BC / ACCESSWIRE / April 24, 2024 / Tryp Therapeutics, Inc. (" Tryp " or the " Company ") ( CSE:TRYP) (OTCQB:TRYPF) is pleased to announce that the shareholders of Exopharm Limited ACN 163 765 ...
|
Wednesday, April 24, 2024 03:15 AM
KELOWNA, BC / ACCESSWIRE / April 24, 2024 / Tryp Therapeutics, Inc. (" Tryp " or the " Company ") ( CSE:TRYP) (OTCQB:TRYPF) is pleased to announce that the shareholders of Exopharm Limited ACN 163 765 ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
23/04/24 | 1.47 | 1.47 | 1.44 | 1.445 | 1,986 |
22/04/24 | 1.48 | 1.48 | 1.42 | 1.4699 | 19,248 |
19/04/24 | 1.45 | 1.48 | 1.45 | 1.45 | 3,716 |
18/04/24 | 1.47 | 1.48 | 1.4301 | 1.48 | 2,031 |
17/04/24 | 1.4597 | 1.49 | 1.43 | 1.45 | 3,600 |
16/04/24 | 1.43 | 1.46 | 1.43 | 1.46 | 2,258 |
15/04/24 | 1.42 | 1.50 | 1.42 | 1.49 | 11,400 |
12/04/24 | 1.43 | 1.50 | 1.43 | 1.45 | 2,554 |
11/04/24 | 1.52 | 1.52 | 1.43 | 1.47 | 2,938 |
10/04/24 | 1.45 | 1.47 | 1.42 | 1.42 | 1,849 |
|
|
||||
|
|
||||
|
|